At $0.82 a share, Phio Pharmaceuticals (PHIO) CEO buys 25,000 shares.
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
Phio Pharmaceuticals Corp.'s Chairman, President, and CEO, Robert J. Bitterman, purchased 25,000 common shares at $0.82 each on November 9, 2026. This transaction increased his direct holdings to 789,871 shares, including unvested restricted stock units. The Form 4 filing indicates a positive sentiment and a 3.3% increase in his position.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.